CASI - CASI Pharmaceuticals GAAP EPS of -$3.01 misses by $2.64 revenue of $43.12M beats by $32.31M
2023-04-26 13:30:58 ET
- CASI Pharmaceuticals press release ( NASDAQ: CASI ): Q4 GAAP EPS of -$3.01 misses by $2.64 .
- Revenue of $43.12M beats by $32.31M .
For further details see:
CASI Pharmaceuticals GAAP EPS of -$3.01 misses by $2.64, revenue of $43.12M beats by $32.31M